Imperial partners with EnteroBiotix to advance microbiome medical treatments

Photo: Imperial College London website. Imperial is partnering with biotechnology company EnteroBiotix on research into the potential of therapies based on the gut bacterial community.

Related Keywords

United Kingdom ,London ,City Of ,Jiri Pavlu ,Rohma Ghani ,Frances Davies ,Andrew Innes ,Benjamin Mullish ,James Kinross ,Julian Marchesi ,James Mcilroy ,Department Of Surgery Cancer ,King College London ,Imperial College London ,Research Council ,Department Of Metabolism ,University Hospitals Birmingham ,Imperial College ,Medical Research Council ,Developmental Pathway Funding Scheme ,Microbiota Transplant Prior ,Allogeneic Stem Cell Transplantation ,Professor Julian Marchesi ,Royal Marsden ,College London ,Leeds Teaching Hospitals ,University Hospitals ,